关注公众号
收藏产品 产品详情
组分（Materials Provided）
BoxA(-20°C)IDComponentsSizeADC-P005-C0120 x Reaction buffer55ulADC-P005-C02Cofactor A55ulADC-P005-C03Cofactor B55ulADC-P005-C04Substrate A30ulADC-P005-C05Substrate B30ulADC-P005-C06Enzyme A30ulADC-P005-C07Enzyme B30ulADC-P005-C08Enzyme C25ulBoxB(4°C)IDComponentsSizeADC-P005-1-C01Binding buffer15mlADC-P005-1-C02Elution buffer1.5mlADC-P005-1-C03Neutralization buffer0.5mlADC-P005-1-C04250 mM Tris-HCl buffer (pH7.5)1.5mlADC-P005-1-C0510×PBS (pH7.2- 7.4)6mlADC-P005-1-C06Desalting column2perADC-P005-1-C07Concentrator tube2perADC-P005-1-C08ProteinA Resin100ul×2背景（Background）
Antibody-drug conjugates (ADC) is a type of fast growing anticancer drug. Monoclonal antibody is conjugated to the cytotoxic payload via a chemical linker that directed toward a target antigen expressed on the cancer cell surface, reducing systemic exposure and therefore toxicity. AGLink® ADC conjugation kit is designed to conjugate mAb with toxic payload (MMAE) though site-specific enzymatic reaction.
应用说明（Application）
AGLink® ADC Conjugation Kit (MMAE, DAR2&4, 1mg) is designed to conjugate 1mg mAb with toxic payload (MMAE) through site-specific enzymatic reaction.
It is for research use only.
优势特色（Features）
- Site-specific conjugation through Fc-glycan with high conjugation efficiency
- Uniform DAR value and highly homogeneous ADC products
- No need of amino acid sequence engineering
- Easy to use: One-pot & One-step
- Two options: DAR2 & DAR4 ADC product
存储（Storage）
BoxA: The unopened kit is stable for 12 months from the date of manufacture if stored under temperature ≤ -20°C. The opened kit should be stored according to components table.
BoxB: The unopened kit is stable for 12 months from the date of manufacture if stored under 4°C. The opened kit should be stored according to components table.
质量管理控制体系（QMS）
产品展示
典型数据-Typical Data
Please refer to DS document for the assay protocol.
ADC DAR value assessment by RP-HPLC
DAR (Drug Antibody Ratio) value of ADC product was analyzed by RP-HPLC (QC tested).
Column: TSK gel Butyl-NPR column (4.6 mm × 35 mm, 2.5μm; TOSOH)
Mobile phase A：20 mM sodium phosphate, 1.5 M ammonium sulfate (pH 6.9)
Mobile phase B：75% (v/v) 20 mM sodium phosphate, 25% (v/v) isopropanol (pH 6.9)
Flow rate: 0.4 mL/min
Column temperature: 30 °C Detection wavelength：280nm
Loading Amount:10 µg (5-10 µL)
DAR (Drug Antibody Ratio) value of ADC product was analyzed by RP-HPLC (QC tested).
DAR4 =(0*1.5+1*4.38+2*2.25+3*7+4*84.88)/100=3.694
DAR2＝(0*0.52+2*99.48)/100=1.9896
ADC DAR value assessment by RP-HPLC
DAR (Drug Antibody Ratio) value of ADC product was analyzed by RP-HPLC (QC tested).
Column: TSK gel Butyl-NPR column (4.6 mm × 35 mm, 2.5μm; TOSOH)
Mobile phase A：20 mM sodium phosphate, 1.5 M ammonium sulfate (pH 6.9)
Mobile phase B：75% (v/v) 20 mM sodium phosphate, 25% (v/v) isopropanol (pH 6.9)
Flow rate: 0.4 mL/min
Column temperature: 30 °C Detection wavelength：280nm
Loading Amount:10 µg (5-10 µL)
DAR (Drug Antibody Ratio) value of ADC product was analyzed by RP-HPLC (QC tested).
DAR4 =(0*1.5+1*4.38+2*2.25+3*7+4*84.88)/100=3.694
DAR2＝(0*0.52+2*99.48)/100=1.9896
用户评价 发表评论
重要声明
Statement of Rights
AGLink products are co-developed by ACROBiosystems Co., Ltd. and Glyco-therapy Biotechnology Co., Ltd. based on Glyco-therapy's conjugation platform (YTConju?) and are not authorized for commercial use. The sale and use of AGLink products doesn't represent any forms of license or authorization of the attached technologies for developing any diagnostic, therapeutic or prophylactic products for commercial purposes.
Note of application
AGLink products are intended for research use only by the Buyer or its users and can not be used for any other purposes, including, but not limited to, use for any clinical diagnostic type use, in vitro or in vivo therapeutic use, prophylactic use, any type of consumption or application to human or animals.
联系我们 
项目合作